2GVC image
Deposition Date 2006-05-02
Release Date 2006-06-06
Last Version Date 2024-11-13
Entry Detail
PDB ID:
2GVC
Keywords:
Title:
Crystal structure of flavin-containing monooxygenase (FMO)from S.pombe and substrate (methimazole) complex
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.22 Å
R-Value Free:
0.26
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:monooxygenase
Gene (Uniprot):fmo1
Chain IDs:A, B, C (auth: D), D (auth: E)
Chain Length:447
Number of Molecules:4
Biological Source:Schizosaccharomyces pombe
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
MSE A MET SELENOMETHIONINE
Primary Citation
Mechanism of action of a flavin-containing monooxygenase.
Proc.Natl.Acad.Sci.Usa 103 9832 9837 (2006)
PMID: 16777962 DOI: 10.1073/pnas.0602398103

Abstact

Elimination of nonnutritional and insoluble compounds is a critical task for any living organism. Flavin-containing monooxygenases (FMOs) attach an oxygen atom to the insoluble nucleophilic compounds to increase solubility and thereby increase excretion. Here we analyze the functional mechanism of FMO from Schizosaccharomyces pombe using the crystal structures of the wild type and protein-cofactor and protein-substrate complexes. The structure of the wild-type FMO revealed that the prosthetic group FAD is an integral part of the protein. FMO needs NADPH as a cofactor in addition to the prosthetic group for its catalytic activity. Structures of the protein-cofactor and protein-substrate complexes provide insights into mechanism of action. We propose that FMOs exist in the cell as a complex with a reduced form of the prosthetic group and NADPH cofactor, readying them to act on substrates. The 4alpha-hydroperoxyflavin form of the prosthetic group represents a transient intermediate of the monooxygenation process. The oxygenated and reduced forms of the prosthetic group help stabilize interactions with cofactor and substrate alternately to permit continuous enzyme turnover.

Legend

Protein

Chemical

Disease

Primary Citation of related structures